Device Trial Radar · NCT01115465
Study of Macroplastique Safety and Effectiveness in the Treatment of Female Stress Urinary Incontinence
Last checked: Nov 20, 2026Latest source record: Mar 11, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
276
Actual
Start
Jan 2008
Primary completion
Dec 2021
Study completion Feb 2022
Sponsor
- Lead sponsor
- Uroplasty, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 4, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The ROSE Registry will determine the long-term safety and effectiveness of Macroplastique in the treatment of female stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD).
Conditions
- Stress Urinary Incontinence
Interventions
MacroplastiqueDevice
Macroplastique is an injectable soft-tissue bulking agent used to treat stress urinary incontinence (SUI) primarily due to intrinsic sphincter deficiency (ISD).
Primary outcomes
What the sponsor says the trial is designed to measure.
- To describe the incidence of additional or alternative treatment for stress urinary incontinence due to ISD following up to two Macroplastique treatments over a 5 year period.Time frame: 5-years
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Urological Associates of Southern Arizona
Tucson, Arizona
Kaiser Permanente Southern California-Irvine Medical Center
Irvine, California
Univeristy of California- Irvine
Orange, California
16 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.